Related Experiment Videos
History of drug use
National Institute on Drug Abuse Research Monograph Series
|October 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The intimate connection between antisocial personality and substance abuse.
Social psychiatry and psychiatric epidemiology·1998
Detecting errors in a scoring program: a method of double diagnosis using a computer-generated sample.
Social psychiatry and psychiatric epidemiology·1998
Increasing brain tumor rates: is there a link to aspartame?
Journal of neuropathology and experimental neurology·1996
Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force.
The British journal of psychiatry. Supplement·1996
A short computer interview for obtaining psychiatric diagnoses.
Psychiatric services (Washington, D.C.)·1996
The Diagnostic Interview Schedule for Children (PC-DISC v.3.0): parents and adolescents suggest reasons for expecting discrepant answers.
Journal of abnormal child psychology·1995
Development of Chronomers tm for narcotic antagonists.
National Institute on Drug Abuse research monograph series·1976
Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists.
National Institute on Drug Abuse research monograph series·1976
Sustained release of naltrexone from glyceride implants.
National Institute on Drug Abuse research monograph series·1976
Long-acting narcotic antagonist complexes.
National Institute on Drug Abuse research monograph series·1976
Development of injectable microcapsules for use in the treatment of narcotic addiction.
National Institute on Drug Abuse research monograph series·1976
Testing of drug delivery systems for use in the treatment of narcotic addiction.
National Institute on Drug Abuse research monograph series·1976
Population Pharmacokinetic and Pharmacodynamic Analysis of Imipenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Drug design, development and therapy·2026
Medication Safety and Perioperative Risk Management of GLP-1 Receptor Agonists: A Pharmacist-Led Framework for Individualized Care.
Therapeutics and clinical risk management·2026
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
Frontiers in neuroscience·2026
Multidimensional characterization of heterogeneity in pesticide co-exposure patterns.
Frontiers in chemistry·2026
Frustration brake failure hypothesis of substance use disorders.
Frontiers in psychiatry·2026